Selecta Biosciences, Inc. (SELB) At $10.83 Forms Bottom; 8 Analysts Covering Macerich Company (MAC)

Among 24 analysts covering The Macerich Company (NYSE:MAC), 8 have Buy rating, 2 Sell and 14 Hold. Therefore 33% are positive. The Macerich Company had 67 analyst reports since July 21, 2015 according to SRatingsIntel. Bank of America downgraded the stock to “Neutral” rating in Monday, March 28 report. Mizuho maintained it with “Hold” rating and $63.0 target in Friday, February 16 report. KeyBanc Capital Markets maintained the stock with “Buy” rating in Sunday, August 27 report. The company was maintained on Friday, August 4 by Boenning & Scattergood. On Tuesday, May 30 the stock rating was downgraded by Mizuho to “Neutral”. The company was maintained on Tuesday, January 23 by Sandler O’Neill. The rating was upgraded by J.P. Morgan to “Buy” on Tuesday, September 26. The stock of Macerich Company (NYSE:MAC) has “Hold” rating given on Tuesday, January 23 by Jefferies. Mizuho upgraded the shares of MAC in report on Monday, November 7 to “Buy” rating. The rating was maintained by Stifel Nicolaus with “Hold” on Tuesday, February 7. See Macerich Company (NYSE:MAC) latest ratings:

20/04/2018 Broker: Mizuho Rating: Buy New Target: $65.0000 Upgrade
20/04/2018 Broker: BMO Capital Markets Rating: Buy New Target: $66.0000 Upgrade
03/04/2018 Broker: SunTrust Rating: Hold New Target: $57.0000 Maintain
28/03/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Hold Old Target: $62 New Target: $64 Maintain
27/03/2018 Broker: J.P. Morgan Rating: Hold New Target: $65.0000 Downgrade
27/03/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Neutral Downgrade
19/03/2018 Broker: Sandler O’Neill Rating: Hold New Target: $63.0 Maintain
14/03/2018 Broker: BTIG Research Rating: Buy New Target: $66.0
16/02/2018 Broker: Mizuho Rating: Hold New Target: $63.0 Maintain
12/02/2018 Broker: RBC Capital Markets Rating: Hold New Target: $63.0 Maintain

Selecta Biosciences, Inc. (SELB) formed multiple bottom with $10.29 target or 5.00% below today’s $10.83 share price. Selecta Biosciences, Inc. (SELB) has $242.05 million valuation. The stock increased 0.19% or $0.02 during the last trading session, reaching $10.83. About 82,262 shares traded. Selecta Biosciences, Inc. (NASDAQ:SELB) has declined 20.81% since May 8, 2017 and is downtrending. It has underperformed by 32.36% the S&P500.

The stock increased 0.63% or $0.37 during the last trading session, reaching $58.64. About 941,917 shares traded. Macerich Company (NYSE:MAC) has declined 12.03% since May 8, 2017 and is downtrending. It has underperformed by 23.58% the S&P500.

Investors sentiment increased to 1.09 in 2017 Q4. Its up 0.14, from 0.95 in 2017Q3. It improved, as 28 investors sold Macerich Company shares while 106 reduced holdings. 56 funds opened positions while 90 raised stakes. 135.39 million shares or 0.30% more from 134.98 million shares in 2017Q3 were reported. Schwab Charles Invest Mgmt reported 0.06% stake. Water Island Cap reported 75,000 shares. Independent Order Of Foresters invested in 4.12% or 70,878 shares. Royal Bancorporation Of Canada reported 271,243 shares or 0.01% of all its holdings. Amer Insur Commerce Tx, Texas-based fund reported 21,659 shares. Sun Life Finance Inc has invested 0.2% in Macerich Company (NYSE:MAC). Guardian Life Insurance Of America owns 352 shares. Fjarde Ap holds 0.04% of its portfolio in Macerich Company (NYSE:MAC) for 35,603 shares. Quantbot Limited Partnership stated it has 6,908 shares or 0.04% of all its holdings. Riverhead Cap Mngmt Lc invested 0.01% of its portfolio in Macerich Company (NYSE:MAC). Adelante Cap Management Limited Liability Corporation reported 217,776 shares. Employees Retirement System Of Texas reported 0.09% in Macerich Company (NYSE:MAC). 8,175 are held by Cadence Cap Management Limited Liability Com. Element Capital Mngmt Limited Liability Com accumulated 325,764 shares or 0.53% of the stock. Nuveen Asset Mngmt Ltd Liability Com reported 3,049 shares.

The Macerich Company is an independent real estate investment trust. The company has market cap of $8.87 billion. The firm invests in the real estate markets of the United States. It has a 57.49 P/E ratio. It primarily engages in acquisition, ownership, development, redevelopment, management and leasing of regional and community shopping centers located throughout the United States.

Macerich Company (NYSE:MAC) Institutional Positions Chart